people at high risk of pneumococcal disease, an infection that causes pneumonia—children younger than 2, adults older than 64, and those with certain chronic health conditions such as diabetes ...

The Centers for Disease Control and Prevention changed the recommended age for getting the vaccine for pneumococcal pneumonia from those 65 and older to those 50 and above. Fifty is also the age when ...

However, increase in disease-causing or colonizing pneumococcal strains with intermediate resistance due to selective pressure can become a clinical concern. Therefore, changing trends should be ...

There are around 100 different pneumococcal serotypes, causing non-invasive disease like pneumonia, confined to the lungs, and invasive disease, where the infection can spread to the bloodstream ...

The pneumococcal polysaccharide vaccine (PPV) is currently recommended for older adults and high-risk subjects, including patients with chronic obstructive pulmonary disease (COPD) and asthma.

The company is adopting a "portfolio strategy" to pneumococcal disease, with "tailored…vaccines to meet the specific needs of different populations," said Dr Eliav Barr, the drugmaker's chief ...

Vaccination and HIV treatment reduce the risk of invasive pneumococcal disease. Pneumococcal disease is treated with antibiotics. Pneumococcal disease is caused by a bacterium called Streptococcus ...

Pneumococcal vaccine polyvalent ... efficacy was 65–84% among specific patients groups (eg, diabetes mellitus, coronary vascular disease, congestive heart failure, chronic pulmonary disease ...